Likewise, mutations in BRCA1, BRCA2, PALB2, and other components with the HR pathway are common in familial and certain subtypes of sporadic breast cancer, particularly triple negative breast cancer (91–, 93). This evidence concerns the gene BRCA2 and triple-negative breast carcinoma.